Wilfong Diane E.
Known title: SVP, Controller & CAOCIK: 0001374988
Associated companies
Transaction History
| GILD | ▲ Buy | Option Exercise | 921 | — | 9/10/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 338 | $39K | 9/10/2025 | View on chart |
| GILD | ▲ Buy | Option Exercise | 920 | — | 6/10/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 340 | $37K | 6/10/2025 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 565 | $49K | 2/6/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 1,864 | — | 2/6/2023 | View on chart |
| GILD | ▲ Buy | Grant | 4,100 | $0 | 1/24/2023 | View on chart |
| GILD | ▲ Buy | Grant | 1,784 | $0 | 1/24/2023 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 1,244 | $105K | 1/24/2023 | View on chart |
| GILD | ▲ Buy | Option Exercise | 318 | — | 12/10/2022 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 149 | $13K | 12/10/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 6,416 | $410K | 11/9/2022 | View on chart |
| GILD | ▼ Sell | Open Market | 6,416 | $536K | 11/9/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 16,255 | $1.2M | 11/1/2022 | View on chart |
| GILD | ▼ Sell | Open Market | 16,255 | $1.3M | 11/1/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 318 | — | 9/10/2022 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 148 | $10K | 9/10/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 2,479 | — | 8/10/2022 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 1,066 | $67K | 8/10/2022 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 148 | $9K | 6/10/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 317 | — | 6/10/2022 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 935 | $54K | 3/10/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 1,272 | $0 | 3/10/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 2,025 | $0 | 3/10/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 1,864 | $0 | 2/6/2022 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 520 | $33K | 2/6/2022 | View on chart |
| GILD | ▲ Buy | Grant | 1,714 | $0 | 1/26/2022 | View on chart |
| GILD | ▲ Buy | Grant | 1,157 | $0 | 1/26/2022 | View on chart |
| GILD | ▼ Sell | Tax Withholding | 394 | $27K | 1/26/2022 | View on chart |
| GILD | ▲ Buy | Option Exercise | 9,781 | $672K | 8/17/2021 | View on chart |
| GILD | ▲ Buy | Option Exercise | 3,829 | $254K | 8/17/2021 | View on chart |
| GILD | ▼ Sell | Open Market | 13,610 | $987K | 8/17/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Gilead Signs $1.9B Deal With Vir For T-Cell Engagers
Gilead Sciences has entered a $1.9 billion partnership with Vir to develop next-generation T-cell engagers, a move aimed at expanding its oncology pipeline. This strategic agreement coincides with the stock reaching record highs as investors show renewed interest in the healthcare sector. The deal provides a new catalyst for the company ahead of its scheduled third-quarter financial results release.
Gilead Signs $1.9B Deal With Vir For T-Cell Engagers. Gilead Sciences has entered a $1.9 billion partnership with Vir to develop next-generation T-cell engagers, a move aimed at expanding its oncology pipeline. This strategic agreement coincides with the stock reaching record highs as investors show renewed interest in the healthcare sector. The deal provides a new catalyst for the company ahead of its scheduled third-quarter financial results release.